Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone

References

• Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond). 2019;39(1):22.
   PubMed Web of Science ®Google Scholar
• Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982–999.
   PubMed Web of Science ®Google Scholar
• Puijk RS, Ruarus AH, Vroomen L, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial. BMC Cancer. 2018;18(1):821.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359–369.
   PubMed Web of Science ®Google Scholar
• Bellier J, De Wolf J, Hebbar M, et al. Repeated resections of hepatic and pulmonary metastases from colorectal cancer provide long-term survival. World J Surg. 2018;42(4):1171–1179.
   PubMed Web of Science ®Google Scholar
• Feliberti EC, Wagman LD. Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control. 2006;13(1):48–51.
   PubMedGoogle Scholar
• Engstrand J, Nilsson H, Jansson A, et al. A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases – a safety and feasibility study of a new concept. Eur J Surg Oncol. 2014;40(11):1488–1493.
   PubMed Web of Science ®Google Scholar
• Pan Z, Peng J, Lin J, et al. Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection? Cancer Commun (Lond). 2018;38(1):29.
   PubMed Web of Science ®Google Scholar
• Joo JH, Park J-h, Kim JC, et al. Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys. 2017;99(4):876–883.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014;25(11):1706–1708.
   PubMed Web of Science ®Google Scholar
• Nieuwenhuizen S, Puijk RS, van den Bemd B, et al. Resectability and ablatability criteria for the treatment of liver only colorectal metastases: multidisciplinary consensus document from the COLLISION Trial Group. Cancers (Basel). 2020;12(7):1779.
   PubMed Web of Science ®Google Scholar
• Hof J, Wertenbroek MWJLAE, Peeters PMJG, et al. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br J Surg. 2016;103(8):1055–1062.
   PubMed Web of Science ®Google Scholar
• Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an International Panel of Ablation Experts, the Interventional Oncology Sans Frontières Meeting 2013. Eur Radiol. 2015;25(12):3438–3454.
   PubMed Web of Science ®Google Scholar
• Mise Y, Aloia TA, Brudvik KW, et al. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg. 2016;263(1):146–152.
   PubMed Web of Science ®Google Scholar
• Meijerink MR, Puijk RS, van Tilborg A, et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018;41(8):1189–1204.
   PubMed Web of Science ®Google Scholar
• Shibata T, Niinobu T, Ogata N, et al. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89(2):276–284.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Shimada H, Nagano Y, et al. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery. 2006;139(2):263–273.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–968.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng J, Chen H, et al. A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation. Int J Hyperthermia. 2018;34(6):853–862.
   PubMed Web of Science ®Google Scholar
• Song P, Sheng L, Sun Y, et al. The clinical utility and outcomes of microwave ablation for colorectal cancer liver metastases. Oncotarget. 2017;8(31):51792–51799.
   PubMedGoogle Scholar
• Smolock AR, Lubner MG, Ziemlewicz TJ, et al. Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective. AJR Am J Roentgenol. 2015;204(1):197–203.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268–275.e1.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes – a 10-year experience at a single center. Radiology. 2016;278(2):601–611.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
   PubMed Web of Science ®Google Scholar
• Wu W, Xue Y, Wang D, et al. A simulator for percutaneous hepatic microwave thermal ablation under ultrasound guidance. Int J Hyperthermia. 2014;30(7):429–437.
   PubMed Web of Science ®Google Scholar
• Tinguely P, Dal G, Bottai M, et al. Microwave ablation versus resection for colorectal cancer liver metastases – a propensity score analysis from a population-based nationwide registry. Eur J Surg Oncol. 2020;46(3):476–485.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Berber E. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg Nutr. 2020;9(1):49–58.
   PubMed Web of Science ®Google Scholar
• Philips P, Groeschl RT, Hanna EM, et al. Single-stage resection and microwave ablation for bilobar colorectal liver metastases. Br J Surg. 2016;103(8):1048–1054.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205–216.
   PubMed Web of Science ®Google Scholar
• de Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248(4):626–637.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous C, Erinjeri J, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Br J Surg. 2017;104(5):570–579.
   PubMed Web of Science ®Google Scholar
• Cornelis FH, Petre EN, Vakiani E, et al. Immediate postablation 18F-FDG injection and corresponding SUV are surrogate biomarkers of local tumor progression after thermal ablation of colorectal carcinoma liver metastases. J Nucl Med. 2018;59(9):1360–1365.
   PubMed Web of Science ®Google Scholar
• Odisio B, Yamashita S, Huang S, et al. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017;104(6):760–768.
   PubMed Web of Science ®Google Scholar
• Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705.
   PubMed Web of Science ®Google Scholar
• Kurilova I, Bendet A, Petre EN, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clin Colorectal Cancer. 2020:S1533–0028(20)30134–1. DOI:https://doi.org/10.1016/j.clcc.2020.09.005. [Online ahead of print]. PMID: 33246789.
   PubMed Web of Science ®Google Scholar
• Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.
   PubMedGoogle Scholar
• Owen JW, Fowler KJ, Doyle MB, et al. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging. HPB (Oxford). 2016;18(3):296–303.
   PubMed Web of Science ®Google Scholar
• Auer RC, White RR, Kemeny NE, et al. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer. 2010;116(6):1502–1509.
   PubMed Web of Science ®Google Scholar
• van Vledder MG, de Jong MC, Pawlik TM, et al. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg. 2010;14(11):1691–1700.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Takakura H, Takeda K, et al. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg. 2009;250(6):935–942.
   PubMed Web of Science ®Google Scholar
• Elias D, Youssef O, Sideris L, et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol. 2004;86(1):4–9.
   PubMed Web of Science ®Google Scholar
• Jones EL, Halpern AL, Carmichael H, et al. Hepatic ablation promotes colon cancer metastases in an immunocompetent murine model. Ann Surg. 2019;270(4):675–680.
   PubMed Web of Science ®Google Scholar
• Arita J, Ono Y, Takahashi M, et al. Routine preoperative liver-specific magnetic resonance imaging does not exclude the necessity of contrast-enhanced intraoperative ultrasound in hepatic resection for colorectal liver metastasis. Ann Surg. 2015;262(6):1086–1091.
   PubMed Web of Science ®Google Scholar
• Pak LM, Gagniere J, Allen PJ, et al. Utility of image guidance in the localization of disappearing colorectal liver metastases. J Gastrointest Surg. 2019;23(4):760–767.
   PubMed Web of Science ®Google Scholar
• Kim KH, Yoon YS, Yu CS, et al. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011;81(1):25–34.
   PubMedGoogle Scholar
• Adam R, Wicherts DA, de Haas RJ, et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol. 2008;26(10):1635–1641.
   PubMed Web of Science ®Google Scholar
• Peng S, Huang P, Yu H, et al. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine (Baltimore). 2018;97(10):e0044.
   PubMed Web of Science ®Google Scholar
• Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28(7):2727–2734.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Odisio BC, Huang SY, et al. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol. 2017;43(6):1040–1049.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre E, Vakiani E, et al. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget. 2017;8(39):66117–66127.
   PubMedGoogle Scholar
• Marques MC, Ribeiro HSC, Costa WL, et al. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)? J Surg Oncol. 2018;117(5):858–863.
   PubMed Web of Science ®Google Scholar
• Creasy JM, Sadot E, Koerkamp BG, et al. Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? Surgery. 2018;163(6):1238–1244.
   PubMed Web of Science ®Google Scholar
• Sofocleous C, Garg S, Petrovic L, et al. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol. 2012;19(13):4262–4269.
   PubMed Web of Science ®Google Scholar
• Sofocleous C, Petre E, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22(6):755–761.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu X, Liang P, et al. Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? Lessons from 10 years' experience. Oncotarget. 2017;8(59):100791–100800.
   PubMedGoogle Scholar